HE Kun 1,2 , GAO Xiaojin 1,2 , XIE Mengyi 1,2 , LI Jingdong 1,2
  • 1. Clinical Medical College of North Sichuan Medical College, Nanchong, Sichuan 637000, P. R. China;
  • 2. The First Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College; Institute of Hepatobiliary, Pancreatic and Intestinal Diseases, North Sichuan Medical College, Nanchong, Sichuan 637000, P. R. China;
LI Jingdong, Email: lijingdong358@nsmc.edu.cn
Export PDF Favorites Scan Get Citation

Objective To understand the clinical value of centromere proteins (CENPs) in hepatocellular carcinoma and their influence on the malignant biological behavior of hepatocellular carcinoma, and to provide theoretical references for related research in this field. Method Domestic and international databases were searched for relevant literatures on the study of CENPs in hepatocellular carcinoma in recent years to be analyzed and reviewed. Results A total of 11 CENPs closely related to hepatocellular carcinoma had been summarized, which were differentially expressed in hepatocellular carcinoma and correlated with prognosis. CENPs might regulate various malignant biological behaviors such as hepatocellular carcinoma proliferation, metastasis, apoptosis, and resistance to radiotherapy and thus participate in the development of hepatocellular carcinoma via multiple mechanisms. The roles and mechanisms of some CENPs in hepatocellular carcinoma remained unclear. Conclusions CENPs play an essential role in the diagnosis, treatment, and prognosis of hepatocellular carcinoma. They are involved in multiple malignant biological behaviors of hepatocellular carcinoma and are expected to be potential therapeutic targets for hepatocellular carcinoma. However, their roles and mechanisms in hepatocellular carcinoma remain to be investigated.

Citation: HE Kun, GAO Xiaojin, XIE Mengyi, LI Jingdong. Progress in regulation of centromere protein family on malignant biological behavior of hepatocellular carcinoma. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2024, 31(6): 761-768. doi: 10.7507/1007-9424.202311056 Copy

  • Previous Article

    Research progress on cholesterol metabolism in the occurrence, development, and diagnosis of pancreatic ductal adenocarcinoma
  • Next Article

    Interpretation of the progress in esophageal cancer treatment in the 2024 American Society of Clinical Oncology Gastrointestinal Cancer Symposium